Insider Trading & Ownership of Bihua Chen

Location
Boston, MA
Summary
The estimated net worth of Bihua Chen is at least $230M dollars as of 01 Oct 2025. Bihua Chen is the Director, 10%+ Owner of BridgeBio Oncology Therapeutics, Inc. and owns shares of Helix Acquisition Corp. II (HLXB) stock worth about $192M. Bihua Chen is the Director of Erasca, Inc. and owns shares of Erasca, Inc. (ERAS) stock worth about $17.2M. Bihua Chen is the Former 10% Owner of MoonLake Immunotherapeutics and owns shares of MoonLake Immunotherapeutics (MLTX) stock worth about $13.9M. Bihua Chen is the Former Director of Biomea Fusion, Inc. and owns shares of Biomea Fusion, Inc. (BMEA) stock worth about $7.33M.
Signature
/s/ Bihua Chen
All Insider Reports
All Insider Reports

Notify me when Bihua Chen files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Bihua Chen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HLXB Helix Acquisition Corp. II Director, 10%+ Owner $192M 11 Aug 2025
ERAS Erasca, Inc. Director $17.2M 22 Jun 2023
MLTX MoonLake Immunotherapeutics Former 10% Owner $13.9M -$46.9M -77.2% 29 Sep 2025
BMEA Biomea Fusion, Inc. Former Director $7.33M 01 Aug 2025

Insider Transactions Reported by Bihua Chen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.